Discover how to refine enterprise value multiples by adjusting for unusual or one-time items, ensuring truly representative valuation metrics in equity analysis.
Ever peek at a company’s EBITDA and think, “Wait a second, this number looks suspiciously high,” then discover a giant lawsuit settlement or big asset sale skewing the results? You’re not alone. Normalization—removing one-time items or non-operational events—is a crucial step in market-based valuation. This is especially important when using Enterprise Value (EV) multiples like EV/EBITDA or EV/EBIT, because one bad (or good) quarter can hush the real story about a firm’s ongoing performance.
Below, we’ll explore the most common adjustments analysts perform to get to a fairer representation of a firm’s earnings and capital structure. We’ll also sprinkle in some first-hand tips—they’re things I wish someone had hammered into my head back when I first fiddled with messy financial statements.
One-time or non-recurring items can turn an otherwise stable performance metric into something that looks completely off. Here are the usual suspects:
• Restructuring Charges: You might see these when a company reorganizes divisions or shutters certain operations. Although restructuring might be part of common business strategy, large lump-sum hits are often treated as non-recurring.
• Lawsuit Settlements: A single major legal settlement (for example, an antitrust penalty) can hammer operating income.
• Impairments: Goodwill or asset impairments can arise from economic turbulences or M&A flops. Treating them as one-off charges helps smooth the historical data for future valuation.
From a practical standpoint, analysts often “add back” these charges to EBIT or EBITDA to see what the numbers look like under normal conditions. Or, in the event of a one-time gain, the costs might be “subtracted out” if that gain artificially boosts results. And yes, the hardest part can be deciding whether an item is genuinely non-recurring or part of the business’s ongoing operational risk.
If a company is in the steel industry but suddenly sells real estate from a dormant facility, the one-time gain is not representative of the ironclad operation’s usual performance. Unless they repeatedly sell off assets as part of their normal business model (which is rare), you’ll want to exclude that spike from any EV multiple calculations.
Take it from personal experience: a small shipping enterprise I evaluated had a banner year solely because they sold several older vessels at well above book value. If I hadn’t removed that $100 million gain, their EV/EBITDA multiple would have looked abnormally cheap—leading to a misleading investment conclusion.
Newer accounting standards under IFRS 16 and US GAAP (ASC 842) require that many operating leases show up on the balance sheet. But the underlying economics can still vary, pushing analysts to consider “traditional” or “capitalized” approaches when adjusting EV and EBITDA:
Historically, operating leases rarely appeared as liabilities. Under IFRS 16, most leases must be capitalized. However, some short-term or low-value leases can remain off-balance-sheet. For valuation, the main question is whether we treat operating leases like debt (with interest expense and depreciation) or keep them purely as rent expense.
If the lease is basically a financing arrangement, many analysts capitalize it by estimating the present value of future lease payments. This sum is then added to net debt to form a “full” EV. Meanwhile, the associated rental expense that was previously operating expense might be split into interest and depreciation. That can boost EBITDA (since EBITDA excludes interest and depreciation) and raise the EV figure. The net effect on EV/EBITDA can vary, but if you’re ignoring large lease obligations, you might incorrectly label a company as less leveraged.
Below is a quick visual outline of how updating the enterprise value calculation might work:
flowchart LR X["Book EV Calculation: <br/> Market Cap + Debt - Cash"] --> Y["Consider Lease Liabilities <br/> (IFRS 16)"] Y --> Z["Add Present Value <br/> of Operating Leases"] Z --> W["Adjusted EV <br/> Includes Lease Obligations"]
Off-balance-sheet items can stealthily hide from standard metrics. If they represent real claims on a business’s future cash flows, ignoring them can bloat valuations.
A chronically underfunded defined-benefit pension plan is effectively a liability, possibly a large one. Some analysts approximate the underfunded portion as “debt” and add it to EV. If a company has a $500 million shortfall in its pension plan, it’s wise to view that as an economic liability that competes for the firm’s cash flows.
Companies in mining, oil and gas, or chemicals may be subject to enormous cleanup costs or contamination liabilities. Similarly, big unresolved lawsuits can lead to major payouts. Including these off-balance-sheet exposures in EV (or at least disclosing them prominently for an adjusted measure) offers a clearer representation of the firm’s capital obligations.
Some industries are famously cyclical: steel, shipping, airlines, semiconductors, you name it. If you take the EV/EBITDA ratio during a massive upswing, you might conclude: “This company is cheap!” Then, during a downturn, you might conclude “This company is expensive!”—while both times missing the big cyclical context.
When a firm’s earnings are near a cycle peak, the EV/EBITDA ratio might look artificially low. At the cycle trough, the ratio might seem excessively high. Neither multiple fairly represents the firm’s normalized state over time.
Many analysts compute an average EBITDA (or revenues) over a specified period (e.g., 3–5 years) or adopt a mid-cycle estimate. You might see something like:
(EBITDA_Year1 + EBITDA_Year2 + EBITDA_Year3) / 3
or a more nuanced approach that weights each year differently if the cycle had unusual macro conditions (like the global financial crisis). This is sometimes called “mid-cycle normalization.”
M&A transactions can produce funky swings in reported earnings or assets, especially if integration is ongoing. Here’s how to handle it:
A recent acquisition might not fully show up in the historical financial statements. Alternatively, large synergy estimates could remain absent from reported EBITDA. Analysts often present “pro forma” financials that assume the acquisition or merger occurred at the start of the period, capturing the combined firm’s full-year effect.
After an acquisition, intangible assets (e.g., trademarks, patents) might be written up to fair value. Depreciation and amortization expenses can shift significantly, causing short-term distortions in EBIT. If intangible amortization drastically changes the income statement, you may want to adjust EBIT or EBITDA to reflect a more stable, long-term level of expense.
On a CFA Level II equity vignette, you might see a question about calculating EV/EBITDA. The twist could be whether you’re expected to adjust for:
A top tip: Always keep consistency. If you add back a restructuring charge to EBITDA, check whether that same item needs to be reflected on the balance sheet—perhaps as a liability or a use of cash—to properly adjust EV. Similarly, if you add lease liabilities to your EV, examine whether you need to adjust the EBITDA to remove rent expense or recharacterize it.
To see how these adjustments flow, check out the diagram below:
flowchart LR A["Raw Operating Income <br/> (EBIT or EBITDA)"] --> B["Identify & Remove <br/> Non-Recurring Items"] B --> C["Review Long-Term <br/> Lease Obligations"] C --> D["Assess Pension & <br/> Off-Balance-Sheet Liabilities"] D --> E["Incorporate M&A <br/> Pro Forma Changes"] E --> F["Normalized Figures <br/> for Valuation"]
In practice, each of these steps can involve a fair bit of detective work, rummaging through footnotes, management discussions, and notes to the financial statements.
• Do your homework on footnotes: A company’s footnotes contain essential hints about one-time charges or incremental liabilities. Don’t skip them.
• Keep track of materiality: Not every small item needs an exhaustive adjustment. Focus on the big-ticket anomalies that actually distort the numbers.
• Inconsistent adjustments: Adding back a one-time charge to EBITDA but forgetting to handle the associated cash or debt on EV can produce a mismatched multiple.
• Over-adjusting: Resist the temptation to label everything “non-recurring.” Some industries have constant “restructurings.” That might be recurring in disguise.
• Normalization: Adjusting reported financial metrics to remove unusual or non-recurring items that can distort the firm’s ongoing economic reality.
• Off-Balance-Sheet Items: Obligations (or assets) that do not appear directly on the balance sheet under certain accounting policies but still represent real economic exposures.
• Mid-Cycle Normalization: Estimating an average level of performance for cyclical industries, typically using average or “through-the-cycle” metrics.
• Pro Forma Adjustments: Adjustments to historical or forecast financial statements to include or exclude significant, recent events (e.g., acquisitions).
• Purchase Price Accounting (PPA): Revaluation of the acquired firm’s assets and liabilities to fair value at the acquisition date, potentially altering future expense patterns.
• IFRS 16 (Leases) and US GAAP ASC 842 (Leases) for in-depth guidance on capitalization of operating leases.
• International Financial Reporting Standards (IFRS) and US GAAP references for pension accounting and environmental liabilities.
• Journal of Applied Corporate Finance articles exploring cyclical normalization and sector-specific adjustments.
• Advanced equity valuation textbooks that cover “Normalization and Adjustments” in detail.
Important Notice: FinancialAnalystGuide.com provides supplemental CFA study materials, including mock exams, sample exam questions, and other practice resources to aid your exam preparation. These resources are not affiliated with or endorsed by the CFA Institute. CFA® and Chartered Financial Analyst® are registered trademarks owned exclusively by CFA Institute. Our content is independent, and we do not guarantee exam success. CFA Institute does not endorse, promote, or warrant the accuracy or quality of our products.